Genetic modulation of mitochondrial function
Genetic modulation of mitochondrial function
批准号:
9542442
负责人:
Michael John Palladino
金额:
$23.44万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2020-03-31
关键词:
5&apos Untranslated RegionsAgingAnimalsAntibodiesBiochemicalBiologyCell NucleusCellsChimeric ProteinsCleaved cellCodeDevelopmentDiseaseDrosophila genusEndoribonucleasesEngineeringExcisionFluorescence MicroscopyGene ExpressionGenesGeneticGenetic TranscriptionGoalsHealthHela CellsHumanInner mitochondrial membraneInternal Ribosome Entry SiteMeasuresMembraneMessenger RNAMethodsMitochondriaMitochondrial DiseasesMitochondrial RNAN-terminalNerve DegenerationNeurodegenerative DisordersNeuromuscular DiseasesNuclearPTGS2 genePhenotypeProcessProteinsPublishingRNAReporterResearchScienceSignal TransductionSiteSyncopeSystemTechnologyTestingTherapeuticTranslation InitiationTranslationsValidationWestern Blottingage relateddesignefficacy testingexperimental studyflygenetic manipulationin vivoknock-downmitochondrial dysfunctionmonomermutantnervous system disordernovelnovel therapeutic interventionnovel therapeuticsoligomycin sensitivity-conferring proteinoverexpressionpreventtooltranscriptomevector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Genetic control of mitochondria is nearly completely lacking, however, the utility of such tools
would be transformative to numerous fields of biomedical science. Developing genetic methods to
knockdown or express/rescue endogenous mitochondrial genes would be a powerful research tool
but would also immediately enable the development of novel therapies. We have developed novel
vectors (mtTRES) that targeted RNAs to mitochondria and shown their ability to reduce the
expression of endogenous genes in animals and human cells. We have also developed vectors
capable of expressing long, coding RNAs to mitochondria allowing us to perform
overexpression/rescue experiments. We propose to utilize mitochondrial-targeted
riboendonucleases as an alternative method to reduce expression of endogenous genes but also
to willfully process mtTRES expressed RNAs and facilitate their efficient expression. The
development of novel methods to genetically manipulate mitochondrial gene expression in animals,
which will be validated in human cells will have a broad impact on the fields of aging, mitochondrial
biology and neurodegenerative disease research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing the first TPI Df therapeutics
-
批准号:10393677
-
项目类别:
-
资助金额:$54.32万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing the first TPI Df therapeutics
-
批准号:10613470
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing the first TPI Df therapeutics
-
批准号:10229007
-
项目类别:
-
资助金额:$54.35万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing a murine TPI Df model
-
批准号:10294798
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
High-content screening for TPI Deficiency therapeutics
-
批准号:10662471
-
项目类别:
-
资助金额:$54.33万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
High-content screening for TPI Deficiency therapeutics
-
批准号:10312211
-
项目类别:
-
资助金额:$57.85万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9036405
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Determining the cellular and molecular basis of mitochondrial encephalomyopathy seizures
-
批准号:9150332
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9411127
-
项目类别:
-
资助金额:$28.68万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9212818
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial RNA transport as a novel therapy
-
批准号:8412983
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8402430
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8646931
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8836557
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8518415
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial RNA transport as a novel therapy
-
批准号:8271020
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial Dysfunction and Progressive Encephalomyopathies
-
批准号:7927102
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial Dysfunction and Progressive Encephalomyopathies
-
批准号:7686654
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Michael John Palladino
-
依托单位:
TEM TOMOGRAPHY OF A DROSOPHILA ATP6 MUTATION
-
批准号:7721714
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2008
-
负责人:Michael John Palladino
-
依托单位:
TEM TOMOGRAPHY OF A DROSOPHILA ATP6 MUTATION
-
批准号:7598374
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2007
-
负责人:Michael John Palladino
-
依托单位:
海外基金